Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Steven Dunder"'
Autor:
Steven Dunder, Evelyn Siu, Kelly Cohn, Caroline Nightingale, Peter Larson, Karri Donahue, Madeline Richey, Jeffrey J. Kirshner, Zexi Chen, H. James Hamrick, Donegan Janet, Melissa Estevez, Sutton Lauren
Publikováno v:
JCO Clinical Cancer Informatics. :719-727
PURPOSE To facilitate identification of clinical trial participation candidates, we developed a machine learning tool that automates the determination of a patient's metastatic status, on the basis of unstructured electronic health record (EHR) data.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b00e1c99f670c5dd78c884bbd1ce53e5
https://doi.org/10.1200/cci.20.00180
https://doi.org/10.1200/cci.20.00180
Autor:
Addison Tolentino, Apar Kishor Ganti, Irfan Vaziri, Danstan Bagenda, Chao M.D. Huang, Jhanelle E. Gray, Poppy E. Deviany, Ann Fetrick, Heidi McKean, K. M. Islam, Mehmet Sitki Copur, June Ryan, Steven Dunder, Trisari Anggondowati
Publikováno v:
Journal of Oncology Practice. 15:e758-e768
PURPOSE: In the United States, lung cancer accounts for 14% of cancer diagnoses and 28% of cancer deaths annually. Because no cure exists for advanced lung cancer, the primary treatment goal is to prolong survival. OBJECTIVES: The study aim was to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028ea62ca8b60286303fbadaf0a7cd5c
https://doi.org/10.1200/jop.18.00734
https://doi.org/10.1200/jop.18.00734
Autor:
Edward Liu, Evelyn Siu, James Hamrick, Kailee Hawkins, Steven Dunder, Karri Donahue, Green Dominic, Madeline Richey, Shailendra Lakhanpal, Sutton Lauren, Addison Shelley, Alexandra Brachfeld
Publikováno v:
Journal of Clinical Oncology. 39:1539-1539
1539 Background: Clinical trial eligibility increasingly requires information found in NGS tests; lack of structured NGS results hinders the automation of trial matching for this criterion, which may be a deterrent to open biomarker-driven trials in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7304dec9510d72028a81ddcdcb4de74e
https://doi.org/10.1200/jco.2021.39.15_suppl.1539
https://doi.org/10.1200/jco.2021.39.15_suppl.1539
Autor:
James Hamrick, Kelly Cohn, Zexi Chen, Larson Peter, Steven Dunder, Jeffrey J. Kirshner, Donegan Janet, Caroline Nightingale, Evelyn Siu, Karri Donahue, Madeline Richey, Sutton Lauren
Publikováno v:
Journal of Clinical Oncology. 38:2051-2051
2051 Background: Efforts to facilitate patient identification for clinical trials in routine practice, such as automating electronic health record (EHR) data reviews, are hindered by the lack of information on metastatic status in structured format.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::698b062ad0a7de426848c19c15500ee0
https://doi.org/10.1200/jco.2020.38.15_suppl.2051
https://doi.org/10.1200/jco.2020.38.15_suppl.2051
Autor:
Carol A. Sherman, Mario L. Meyer, Steven Dunder, Andrew S. Kraft, Alberto J. Montero, Uzair B. Chaudhary, Mark R. Green, John Hayslip, Shanta Salzer
Publikováno v:
BMC Cancer, Vol 7, Iss 1, p 221 (2007)
BMC Cancer
BMC Cancer
Background COX-2 inhibitors, such as celecoxib, and ubiquitin-proteasome pathway inhibitors, such as bortezomib, can down-regulate NF-κB, a transcription factor implicated in tumor growth. The objective of this study was to determine the maximum tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0931f544dbff12bee5d3b291ab18d93
http://www.biomedcentral.com/1471-2407/7/221
http://www.biomedcentral.com/1471-2407/7/221